# April 2026 APA Journals Feature New Research on Cannabis Use Disorder and Stigma > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/2026-cannabis-stigma-research-april-apa-journals/ > **Published:** 2026-04-03T16:16:19-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:31:02-04:00 > **Clinical Summary:** Explore 2026 cannabis stigma research featured in APA journals, highlighting new insights on cannabis use disorder and treatment challenges. --- ✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. Mental HealthResearchSafety Why This Matters Clinicians treating [cannabis use disorder](https://cedclinic.com/sex-differences-cannabis-stress-reactivity-oxytocin/) need to understand whether AI-delivered cognitive-behavioral therapy can match human-delivered interventions, as this knowledge directly impacts treatment accessibility and resource allocation in clinical settings. These findings will help practitioners make evidence-based decisions about incorporating digital therapeutics into their treatment protocols for patients with [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) disorder. Reducing stigma around cannabis use disorder, as addressed in the research, is critical for improving patient disclosure and engagement in treatment, which are fundamental to achieving better clinical outcomes. Dr. Caplan’s Take “The research comparing AI-assisted CBT to human-delivered therapy for cannabis use disorder is clinically important because it forces us to ask what we’re actually treating: the neurobiological dependence, the learned behaviors, or the therapeutic relationship itself, and the answer determines whether a chatbot can substitute for clinical judgment.” Clinical Perspective As artificial intelligence tools become increasingly accessible, preliminary research comparing chatbot-delivered cognitive-behavioral therapy to human-delivered interventions for cannabis use disorder warrants cautious consideration in clinical settings. While digital therapeutics offer potential advantages in accessibility and scalability for patients with substance use disorders, the limited evidence base, questions about therapeutic alliance and real-time clinical responsiveness, and the heterogeneity of cannabis use presentations mean such tools should not yet replace standard evidence-based treatment. Stigma surrounding cannabis use disorder remains a significant barrier to treatment engagement and provider training, and introducing AI-mediated care without careful implementation could potentially worsen these dynamics if patients perceive it as depersonalization. Clinicians should remain informed about emerging digital interventions while recognizing that current evidence supports human-delivered CBT as the gold standard. In practice, any exploration of AI-assisted approaches should occur within integrated care models where human clinicians maintain oversight, provide motivational support 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/mental-health/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+April+2026+issues+of+APA+journals+feature+new+research+on+cannabis+use+disorder%2C+stigma+...+%40drcaplan&url=https%3A%2F%2Fwww.eurekalert.org%2Fnews-releases%2F1122708)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.eurekalert.org%2Fnews-releases%2F1122708)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+April+2026+issues+of+APA+journals+feature+new+research+on+cannabis+use+disorder%2C+stigma+...+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fwww.eurekalert.org%2Fnews-releases%2F1122708)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) Related Articles - [April 2026 Issues of APA Journals Feature New Research on Cannabis Use Disorder …](https://cedclinic.com/ai-assisted-cannabis-use-disorder-treatment-2026/) - April 2026 Issues of APA Journals Feature New Research on Cannabis Use Disorder … 📰 Source: [https://www.eurekalert.org/news-releases/1122708](https://www.eurekalert.org/news-releases/1122708) Further Reading Cannabis Policy Wire[CED Regulatory Digest, Since Last Digest, 2 items](https://cedclinic.com/ced-regulatory-digest-since-last-digest-2-items/) Research Digest[Research Digest: 5 Recent Studies – March 25, 2026](https://cedclinic.com/research-digest-recent-studies-march-2026/) Evidence Watch[Nose-to-Brain Delivery System for Incorporating Monoterpenes with Anti-Depressant Potential.](https://cedclinic.com/monoterpenes-antidepressant-potential-nose-to-brain-delivery/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Is Cannabis Effective for Treating Mental Health Disorders? – Labroots](https://cedclinic.com/cannabis-mental-health-treatment-challenges/) Explore evidence on cannabis effectiveness for mental health disorders, providing context for stigma and treatment research. [Read More](https://cedclinic.com/cannabis-mental-health-treatment-challenges/) [Research Suggests Cannabis Is Ineffective for Depression, Anxiety or PTSD](https://cedclinic.com/cannabis-psychiatric-research-findings-depression-anxiety/) Review research findings on [cannabis and mental health](https://cedclinic.com/endocannabinoid-system-fear-extinction/) conditions, relevant to understanding stigma in cannabis use disorder. [Learn More](https://cedclinic.com/cannabis-psychiatric-research-findings-depression-anxiety/) [Why Older Adults Increasingly Seek Cannabis for Pain, Mental Health, & Sleep](https://cedclinic.com/why-older-adults-increasingly-seek-cannabis-for-pain-mental-health-sleep/) Insights into cannabis use trends among older adults, highlighting factors influencing stigma and treatment approaches. [Explore Article](https://cedclinic.com/why-older-adults-increasingly-seek-cannabis-for-pain-mental-health-sleep/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).